Invention Grant
- Patent Title: Modified kappa light chain-binding polypeptides
-
Application No.: US15526849Application Date: 2015-12-11
-
Publication No.: US10208091B2Publication Date: 2019-02-19
- Inventor: Gustav Rodrigo , Mats Ander , Tomas Bjorkman
- Applicant: GE HEALTHCARE BIOPROCESS R&D AB
- Applicant Address: SE Uppsala
- Assignee: GE HEALTHCARE BIOPROCESS R&D AB
- Current Assignee: GE HEALTHCARE BIOPROCESS R&D AB
- Current Assignee Address: SE Uppsala
- Agency: Eversheds Sutherland (US) LLP
- Priority: SE1451563 20141217; SE1451564 20141217
- International Application: PCT/EP2015/079387 WO 20151211
- International Announcement: WO2016/096643 WO 20160623
- Main IPC: C07K14/195
- IPC: C07K14/195 ; C07K1/22 ; C07K16/00
Abstract:
A kappa light chain-binding polypeptide comprising or consisting essentially of one or more binding domains of Peptostreptococcus Protein L, each of said domains being selected from the group consisting of domain 2, domain 3 and domain 4.
Public/Granted literature
- US20170327545A1 Modified Kappa Light Chain-Binding Polypeptides Public/Granted day:2017-11-16
Information query
